KuoOffice's videos (36)


865
May 26, 2010
Module II - Section 4

Key Therapeutic Area: Neurology http://pharmacogenomics.ucsd.edu/

1106
May 26, 2010
Module II - Section 3

Key Therapeutic Area: Anticoaugulation http://pharmacogenomics.ucsd.edu/

881
May 26, 2010
Module II - Section 2

Key Therapeutic Area: Oncology http://pharmacogenomics.ucsd.edu/

939
May 26, 2010
Module II - Section 1

Key Therapeutic Area: Infectious Disease http://pharmacogenomics.ucsd.edu/

922
May 26, 2010
Module I - Section 5

Ethical Legal Social Issues http://pharmacogenomics.ucsd.edu/

826
May 26, 2010
Module I - Section 4

Patient Case 2 http://pharmacogenomics.ucsd.edu/

955
May 26, 2010
Module I - Section 3

Patient Case 1 http://pharmacogenomics.ucsd.edu/

929
May 26, 2010
Module I - Section 2

Pharmacogenomic Nomenclature

855
May 26, 2010
Module I - Section 1

Translating Pharmacogenomic Into Practice http://pharmacogenomics.ucsd.edu/

1813
Apr 21, 2010
A variant of the HTRA1 gene increases susceptibility to age-related macular...

Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world...

786
Apr 14, 2010
Evaluation of an Educational Program for Women and Pharmacists on Safe Use of...

To increase the awareness of CTIS services for pharmacists and consumers

1671
Feb 16, 2010
Dr. Beatriz Lewis's Pharmacy Practice at UCSD's Moores Cancer Center

The San Diego Pharmacist Resource and Research Network is conducting a study to discover the best...

9334
Nov 23, 2009
PharmGenEd™ Principles and Concepts of Pharmacogenomics

The presentation is divided into several sections as outlined by the powerpoint slide. In this module we will...

4040
Nov 18, 2009
PharmGenEd: Clinical Application of Pharmacogenomics

We will review the use of pharmacogenomic tests in five therapeutic areas. Infectious disease Oncology...